IL33846A - Derivatives of 1-thiachromone and 4-thionchromone,their preparation and pharmaceutical compositions containing them - Google Patents

Derivatives of 1-thiachromone and 4-thionchromone,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL33846A
IL33846A IL33846A IL3384670A IL33846A IL 33846 A IL33846 A IL 33846A IL 33846 A IL33846 A IL 33846A IL 3384670 A IL3384670 A IL 3384670A IL 33846 A IL33846 A IL 33846A
Authority
IL
Israel
Prior art keywords
compound
formula
carbon
pharmaceutically acceptable
group containing
Prior art date
Application number
IL33846A
Other versions
IL33846A0 (en
Original Assignee
Fisons Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Pharmaceuticals Ltd filed Critical Fisons Pharmaceuticals Ltd
Publication of IL33846A0 publication Critical patent/IL33846A0/en
Publication of IL33846A publication Critical patent/IL33846A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00Thiols, sulfides, hydropolysulfides or polysulfides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/92Naphthopyrans; Hydrogenated naphthopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1291864 Anti-asthmatic medicines FISONS PHARMACEUTICALS Ltd 2 Feb 1970 [12 Feb 1969] 7467/69 Heading ASB [Also in Division C2] Therapeutic compositions for the treatment 'extrinsic' and 'intrinsic' asthma, and other conditions, such as hay fever, urticaria and autoimmune diseases, in which antigen-antibody reactions are responsible for disease, by administration orally, parenterally or topically, or by inhalation, comprise compounds of formula: or their pharmaceutically acceptable derivatives (e.g. salts, esters or amides), wherein one of V and W is O, and the other is S; and P, Q, R, T are each H, halogen, C 1-10 alkyl, OH, alkoxy, hydroxyalkoxy, alkoxyalkoxy, AcO, CO 2 H, NH 2 , alkyl-NH, (alkyl) 2 N, alkenyl, aralkyl (up to C 10 ), Ph, NO 2 , carboxylic ester, alkenyloxy or acyl, or an adjacent pair of P, Q, R, T together with the adjacent carbon atoms in the benzene ring form a fused 5- or 6-membered carbocyclic or heterocyclic ring. For administration by inhalation, the compositions may include a bronchodilator such as isoprenaline, adrenaline, orciprenaline, isoetharine or their pharmaceutically acceptable derivatives. [GB1291864A]

Claims (1)

1. 42 CLAMS Processes for the preparation of compounds of the formula in which and which may he the same or each represent an alkyl group containing from 1 to 10 carbon a alkoxy or carboxy the above groups containing up to 10 carbon a carbalkoxy or or an adjacent pair of R and together with the adjacent carbon atoms in the benzene ring may form a fused or 6 cyclic membered V and which are each represent oxygen or provided not all of and are when and are all hydrogen is not a chlorine when I is a methoxy and are 7 is oxygen and W is p is not a methyl when V is sulphur and is one of R and is alkoxy or an adjacent pair of R and T together with the adjacent carbon atoms of the benzene a 6 membered carbocyclic and pharmaceutically acceptable alkyl esters or unsubstituted amides which comprise producing a of formula in which T and the provisos are as defined by cyclising a compound of formula p in which T and the provisos are as defined and represents or an alkali producing a of formula in which provisos are defined by treating a corresponding compound of formula 44 or of P in which III and IV and the provisos are a defined and represents an alkali metal cation or an alkyl with phosphorous pentasulp and where desired converting the compound of I produced a acceptable derivative A process according to part of Claim wherein the cyclisation is carried out in the presence of a dehydrating A process according to part of Claim wherein the cyclisation is effected by converting the groups in the compound of formula II to acyl chloride groups and subjecting the resulting acyl chloride to an internal Friedel Crafts A process according to part of Claim wherein the reaction is carried out at elevated temperature in a solvent which is inert under the reaction A process as claimed in Claim 1 and substantially as hereinbefore described in any one of Examples 1 to A process for the production of a pharmaceutically acceptable salt of a compound of formula as defined in Claim which comprises converting the compound of formula a different salt an ester or an amide thereof to the desired 45 Compounds of formula I in Claim whenever produced by a process according to any one of Claims 1 to Compounds of formula as defined in Claim A compound of formula in which and the provisos are as defined in Claim A compound of formula in which and the provisos are as defined in Claim A compound according to any of Claims 8 to wherein R and which may be the same or each represent bromine or an alkyl group containing from 1 to 6 carbon a hydroxy an group containing from 1 to 10 carbon a carboxy a phenyl a nitro a carbalkoxy group containing from 1 to 6 carbon an group containing from 1 to 6 carbon or R and 46 together with adjacent carbon atoms in the benzene ring form the chains compound according to any of Claims 8 to in which R and which may be the same or each represent chlorine or a nitro or an or group containing from 1 to 6 carboy or an adjacent pair of and form an alkylene or A compound according to any of Claims 8 to wherein P represents lic lic A compound according to any one of Claims 8 to in the form of a pharmaceutically acceptable ester or amide 47 A compound according to any one of Claims 7 to in the form of the sodium salt lie ethyl Ethyl carbox A pharmaceutical composition comprising a compound o formula 48 which R and which may be the same or each represent an alkyl group containing from 1 to 10 carbon a alkoxy or carboxy the above groups containing up to 10 carbon a carbalkoxy or alkenyloxy or an adjacent pair of R and together with the adjacent carbon atoms in the benzene ring may form a fused or 6 cyclic V and which are each Kpresent oxygen or except V is sulphur and W is oxygen one of R and T is alkoxy or an adjacent pair of and T together with the adjacent Carbon atoms of the a 6 membered carbocyclic rin or a pharmaceutically acceptable alkyl ester or unsubstituted amide as active in combinati with a pharmaceutically acceptable diluent or A composition according to Claim wherein the compound of formula I c is a compound according to any one of Claims 7 to A composition according to either of Claims 38 and incorporating a b ronchodilator A composition according to any of Claims 38 to in a form suitable for administration of a dose of from to 50 mgs of active A pharmaceutical composition according to Claim substantially as hereinbefore 49 A composition according to any of Claims 40 and the active ingredient is one of the compounds of 27 to A composition according to any of Claims 40 and wherein the active ingredient is one of the compounds of Claims 30 to composition according to any of Claims 40 and wherein the active ingredient is the compound of Claim insufficientOCRQuality
IL33846A 1969-02-12 1970-02-05 Derivatives of 1-thiachromone and 4-thionchromone,their preparation and pharmaceutical compositions containing them IL33846A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7467/69A GB1291864A (en) 1969-02-12 1969-02-12 Mono thiachromone-2-carboxylic acids

Publications (2)

Publication Number Publication Date
IL33846A0 IL33846A0 (en) 1970-04-20
IL33846A true IL33846A (en) 1976-04-30

Family

ID=9833661

Family Applications (1)

Application Number Title Priority Date Filing Date
IL33846A IL33846A (en) 1969-02-12 1970-02-05 Derivatives of 1-thiachromone and 4-thionchromone,their preparation and pharmaceutical compositions containing them

Country Status (9)

Country Link
JP (2) JPS4835266B1 (en)
CH (5) CH551438A (en)
DE (1) DE2006196A1 (en)
DK (1) DK128420B (en)
FR (1) FR2034538B1 (en)
GB (1) GB1291864A (en)
IL (1) IL33846A (en)
NL (1) NL7001922A (en)
SE (1) SE367634B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1362782A (en) * 1970-08-26 1974-08-07 Fisons Ltd Tetrazole derivatives
BE769146A (en) * 1970-07-01 1971-11-03 Takeda Chemical Industries Ltd CHROMON-CARBOXYLIC ACID DERIVATIVES
GB1391615A (en) * 1971-09-30 1975-04-23 Fisons Ltd 4-oxo-4h-1-benzopyran and 4-oxo-4h-1-thia benzopyran derivatives
JPS50112055U (en) * 1974-02-22 1975-09-12
US4159273A (en) * 1974-11-30 1979-06-26 Fisons Limited Tricyclic mono-chromone-2-carboxylic acids
CA1065329A (en) * 1974-11-30 1979-10-30 Richard Hazard Chromone derivatives
DE3275295D1 (en) * 1981-11-12 1987-03-05 Fisons Plc Anti-srs-a carboxylic acid derivatives, processes for their production, and pharmaceutical formulation containing them
US4778903A (en) * 1983-12-12 1988-10-18 G. D. Searle & Co. Substituted dihydrobenzopyrans
US4888356A (en) * 1983-08-08 1989-12-19 G. D. Searle And Company Use of substituted dihydrobenzopyrans for allergy and inflammation
US4665203A (en) * 1983-08-08 1987-05-12 G. D. Searle & Co. Substituted dihydrobenzopyrans useful as leukotriene D4 inhibitors
US4565882A (en) * 1984-01-06 1986-01-21 G. D. Searle & Co. Substituted dihydrobenzopyran-2-carboxylates
US4644071A (en) * 1984-07-11 1987-02-17 G. D. Searle & Co. Aralkoxy and aryloxyalkoxy kojic acid derivatives

Also Published As

Publication number Publication date
CH551437A (en) 1974-07-15
IL33846A0 (en) 1970-04-20
SE367634B (en) 1974-06-04
JPS4835266B1 (en) 1973-10-26
CH560712A5 (en) 1975-04-15
FR2034538A1 (en) 1970-12-11
DE2006196A1 (en) 1970-11-05
NL7001922A (en) 1970-08-14
CH557811A (en) 1975-01-15
JPS4835267B1 (en) 1973-10-26
CH557346A (en) 1974-12-31
DK128420B (en) 1974-04-29
CH551438A (en) 1974-07-15
FR2034538B1 (en) 1974-08-30
GB1291864A (en) 1972-10-04

Similar Documents

Publication Publication Date Title
CA1087205A (en) 2-amino-3-(5-and 6-)benzoylphenylacetic acids, esters and metal salts thereof
US4440785A (en) Methods of using 2-aminobiphenylacetic acids, esters, and metal salts thereof to treat inflammation
JPS6354321A (en) Blood sugar lowering agent
IL33846A (en) Derivatives of 1-thiachromone and 4-thionchromone,their preparation and pharmaceutical compositions containing them
US3853923A (en) 2-substituted-(2-hydroxy-3-lower alkaminopropoxy)-benzofurans
US3506667A (en) Furo quinoline carboxylates
US4389408A (en) Novel ampicillin esters and production thereof
SE7705637L (en) PROCEDURE FOR THE PREPARATION OF DIBENSOXEPIN DERIVATIVES WITH THERAPEUTIC EFFECT
HUT46895A (en) Process for production of new 5-lipoxigenase bicyclic compounds with inhibiation effect
GB1355147A (en) Oxoprostanoic acid derivatives
US3740437A (en) Naphthyloxyacetic acids and pharmaceutical compositions and methods thereof
IE36716B1 (en) Substituted cyclic urea derivatives and pharmaceutical compositions containing them
US4539326A (en) 5-Oxo-5H-(1)benzopyrano(2,3-b)pyridine derivatives, their production and use as anti-inflammatory agents
GB1353304A (en) Process for production of diketopiperazine dihydroxamates and intermediate therefor
US3306909A (en) 3-carbamoyl-1,5-diphenyl-2,4-pyrrolidinediones
CH640526A5 (en) METHOD FOR PRODUCING NEW BENZOPYRANE DERIVATIVES.
ES8401926A1 (en) Hydroxybenzylamino-aryl compounds, process for preparing and pharmaceutical compositions containing the same.
US3647802A (en) 2-amino-4-aryl-3 4-dihydroquinolines
US3714206A (en) Benzo-2,3,1-diazaborines
EP0000488A1 (en) 3-Oxaloamino-4-oxo-4H-1-benzopyrane compounds, process for their preparation and their pharmaceutical use
US3457273A (en) Derivative of phenylbutazone
GB1384843A (en) Benzofuran derivatives their preparation and compositions containing them
IE33870B1 (en) Benzobenzofuranooxepine compounds and process for preparing the same
US3169127A (en) Derivatives of penicillin amides
US3184463A (en) Piperazines and method of making same